$3.39
0.00%
Nasdaq, Fri, Sep 25 2026.
ISIN
CA88338H1001
Symbol
THTX

Theratechnologies Inc. Stock price

$3.39
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+1.30 62.36% 3Y
-12.29 78.38% 5Y
-5.57 62.15% 10Y
-4.75 58.35% 20Y
Nasdaq, Closing price Fri, Sep 25 2026
+0.00 0.00%
ISIN
CA88338H1001
Symbol
THTX
Industry

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$33.7m
Cash
$9.9m
Shares outstanding
46.0m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-47.4%
Return on Equity
32.9%
ROCE
70.1%
ROIC
195.8%
Debt/Equity
-1.6
Financials (TTM | estimate)
Revenue
$84.4m | $83.9m
EBITDA
$10.4m
EBIT
$8.5m
Net Income
$-9.2m
Free Cash Flow
$-3.1m
Growth (TTM | estimate)
Revenue
2.2% | -2.3%
EBITDA
49.2%
EBIT
125.2%
Net Income
-30.9%
Free Cash Flow
18.7%
Margin
Gross
77.7%
EBITDA
12.4%
EBIT
10.1%
Net
-10.9%
Free Cash Flow
-3.7%
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
0.6%
Employees
103
Rev per Employee
$830.0k

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

Buy
90%
Hold
10%

Theratechnologies Inc. Events

Past Events
SEP
12
Shareholder/Analyst Call - Theratechnologies Inc.
about one year ago

Financial data from Theratechnologies Inc.

May '25
+/-
%
84 84
2% 2%
100%
- Direct Costs 19 19
5% 5%
22%
66 66
5% 5%
78%
- Selling and Administrative Expenses 43 43
8% 8%
51%
- Research and Development Expense 14 14
26% 26%
17%
10 10
49% 49%
12%
- Depreciation and Amortization 1.95 1.95
39% 39%
2%
EBIT (Operating Income) EBIT 8.48 8.48
125% 125%
10%
Net Profit -9.16 -9.16
31% 31%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Mr. Levesque
Employees 103
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today